MPM BioImpact’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-611,181
Closed -$14.4M 42
2023
Q4
$14.4M Buy
611,181
+411
+0.1% +$9.71K 3.38% 11
2023
Q3
$9.11M Buy
+610,770
New +$9.11M 2.43% 15